pharma · Allergies · Early Parkinson Disease
Advanced Accelerator Applications
Advanced Accelerator Applications is a pharma organization headquartered in RUEIL-MALMAISON, FR. Primary therapeutic focus areas include Allergies, Early Parkinson Disease, Breast Cancer, Recurrent or Metastatic Breast C
20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON HQ
590 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- 20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON
- Employees
- 590
- Programs
- 12
- Drugs
- 25
- Patents
- 25
CAAA601A22301
Phase 3 · small molecule · Patients with somatostatin receptor positive, well-differentiated G2 and G3, advanced GEP NETs
CAAA601A22301 for Patients with somatostatin receptor positive, well-differentiated G2 and G3, advanced GEP NETs is a Phase 3 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).
Internal code CAAA601A22301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Advanced Accelerator Applications
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Patients with somatostatin receptor positive, well-differentiated G2 and G3, advanced GEP NETs
- Status
- active
- Trials
- 1